emeriamine has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M | 1 |
| Cabri, W; Carminati, P; Conti, R; Dell'Uomo, N; Gallo, G; Giannessi, F; Mastrofrancesco, L; Ricciolini, R; Tassoni, E; Vincenti, S | 1 |
2 other study(ies) available for emeriamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism | 2011 |
Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I.
Topics: Animals; Betaine; Binding Sites; Carnitine; Carnitine O-Palmitoyltransferase; Computer Simulation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Hypoglycemic Agents; Mice; Rats | 2010 |